콘텐츠로 건너뛰기
Merck
  • Isolation and structural elucidation of two impurities from a diacerein bulk drug.

Isolation and structural elucidation of two impurities from a diacerein bulk drug.

Journal of pharmaceutical and biomedical analysis (2009-01-10)
Chaudhari Ashok, Maikap Golak, Deo Adwait, Vivek Krishna, Agrawal Himani, Peshawe Umesh, Gawande Amol, Sompalli Srinivas, Mane Sharad, Jadhav Deepali, Chaudhari Atul
초록

Two impurities were found in the crude sample of diacerein. The level of these impurities 1.14% and 1.24% were detected by isocratic reverse-phase high performance liquid chromatography (HPLC). The molecular weights of the impurities were determined by liquid chromatography-mass spectroscopy (LC-MS) analysis. These impurities were isolated from crude sample of diacerein by reverse-phase preparative liquid chromatography. These impurities were characterized as 5-acetoxy-4-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic acid (Impurity-1) and 4-acetoxy-5-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic acid (Impurity-2) respectively. Structural elucidation of both the impurities were carried out by (1)H NMR, (13)C NMR, DEPT, 1D NOESY, MS and IR spectroscopy.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Diacerein, ≥95% (HPLC)
Diacerein impurity B, European Pharmacopoeia (EP) Reference Standard